Pesquisa | Portal de Pesquisa da BVS Enfermagem

1.

OV21/PETROC: a randomized Gynecologic Cancer Intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer.

Provencher, D M; Gallagher, C J; Parulekar, W R; Ledermann, J A; Armstrong, D K; Brundage, M; Gourley, C; Romero, I; Gonzalez-Martin, A; Feeney, M; Bessette, P; Hall, M; Weberpals, J I; Hall, G; Lau, S K; Gauthier, P; Fung-Kee-Fung, M; Eisenhauer, E A; Winch, C; Tu, D; MacKay, H J.

Ann Oncol ; 29(2): 431-438, 2018 02 01.

Artigo em Inglês | MEDLINE | ID: mdl-29186319

2.

Real-world evidence in the treatment of ovarian cancer.

Eisenhauer, E A.

Ann Oncol ; 28(suppl_8): viii61-viii65, 2017 Nov 01.

Artigo em Inglês | MEDLINE | ID: mdl-29232466

3.

Multigene expression profile testing in breast cancer: is there a role for family physicians?

O'Brien, M A; Carroll, J C; Manca, D P; Miedema, B; Groome, P A; Makuwaza, T; Easley, J; Sopcak, N; Jiang, L; Decker, K; McBride, M L; Moineddin, R; Permaul, J A; Heisey, R; Eisenhauer, E A; Krzyzanowska, M K; Pruthi, S; Sawka, C; Schneider, N; Sussman, J; Urquhart, R; Versaevel, C; Grunfeld, E.

Curr Oncol ; 24(2): 95-102, 2017 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-28490923

4.

First application of the Automated QUantitative Analysis (AQUA) technique to quantify PTEN protein expression in ovarian cancer: A correlative study of NCIC CTG OV.16.

Weberpals, J I; Amin, M S; Chen, B E; Tu, D; Spaans, J N; Squire, J A; Eisenhauer, E A; Virk, S; Ma, D; Duciaume, M; Hoskins, P; LeBrun, D P.

Gynecol Oncol ; 140(3): 486-93, 2016 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-26775196

5.

A phase II study of SB939, a novel pan-histone deacetylase inhibitor, in patients with translocation-associated recurrent/metastatic sarcomas-NCIC-CTG IND 200.

Chu, Q S-C; Nielsen, T O; Alcindor, T; Gupta, A; Endo, M; Goytain, A; Xu, H; Verma, S; Tozer, R; Knowling, M; Bramwell, V B; Powers, J; Seymour, L K; Eisenhauer, E A.

Ann Oncol ; 26(5): 973-981, 2015 May.

Artigo em Inglês | MEDLINE | ID: mdl-25632070

6.

A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195.

Eigl, B J; North, S; Winquist, E; Finch, D; Wood, L; Sridhar, S S; Powers, J; Good, J; Sharma, M; Squire, J A; Bazov, J; Jamaspishvili, T; Cox, M E; Bradbury, P A; Eisenhauer, E A; Chi, K N.

Invest New Drugs ; 33(4): 969-76, 2015 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-25983041

7.

Performance of multinomial designs in comparison with response-based designs in non-randomized phase II trials of targeted cancer agents.

Jamal, R; Goodwin, R A; Tu, D; Walsh, W; Lacombe, D; Eisenhauer, E A.

Ann Oncol ; 24(7): 1936-1942, 2013 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-23553058

8.

Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199).

Tinker, A V; Ellard, S; Welch, S; Moens, F; Allo, G; Tsao, M S; Squire, J; Tu, D; Eisenhauer, E A; MacKay, H.

Gynecol Oncol ; 130(2): 269-74, 2013 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-23672928

9.

Temsirolimus in combination with carboplatin and paclitaxel in patients with advanced solid tumors: a NCIC-CTG, phase I, open-label dose-escalation study (IND 179).

Kollmannsberger, C; Hirte, H; Siu, L L; Mazurka, J; Chi, K; Elit, L; Walsh, W; Sederias, J; Doyle, A; Eisenhauer, E A; Oza, A M.

Ann Oncol ; 23(1): 238-244, 2012 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-21447615

10.

Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumours.

Razak, A R A; Hotte, S J; Siu, L L; Chen, E X; Hirte, H W; Powers, J; Walsh, W; Stayner, L-A; Laughlin, A; Novotny-Diermayr, V; Zhu, J; Eisenhauer, E A.

Br J Cancer ; 104(5): 756-62, 2011 Mar 01.

Artigo em Inglês | MEDLINE | ID: mdl-21285985

11.

Optimal assessment of response in ovarian cancer.

Eisenhauer, E A.

Ann Oncol ; 22 Suppl 8: viii49-viii51, 2011 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-22180400

12.

A phase II study of sunitinib in patients with recurrent epithelial ovarian and primary peritoneal carcinoma: an NCIC Clinical Trials Group Study.

Biagi, J J; Oza, A M; Chalchal, H I; Grimshaw, R; Ellard, S L; Lee, U; Hirte, H; Sederias, J; Ivy, S P; Eisenhauer, E A.

Ann Oncol ; 22(2): 335-40, 2011 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-20705911

13.

Breast cancer 1 (BRCA1) protein expression as a prognostic marker in sporadic epithelial ovarian carcinoma: an NCIC CTG OV.16 correlative study.

Weberpals, J I; Tu, D; Squire, J A; Amin, M S; Islam, S; Pelletier, L B; O'Brien, A M; Hoskins, P J; Eisenhauer, E A.

Ann Oncol ; 22(11): 2403-2410, 2011 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-21368065

14.

Early integration of palliative care into standard oncology care: evidence and overcoming barriers to implementation.

Kain, D A; Eisenhauer, E A.

Curr Oncol ; 23(6): 374-377, 2016 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-28050132

15.

Update in methodology and conduct of cancer clinical trials.

Therasse, P; Eisenhauer, E A; Buyse, M.

Eur J Cancer ; 42(10): 1322-30, 2006 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-16737813

16.

RECIST revisited: a review of validation studies on tumour assessment.

Therasse, P; Eisenhauer, E A; Verweij, J.

Eur J Cancer ; 42(8): 1031-9, 2006 May.

Artigo em Inglês | MEDLINE | ID: mdl-16616487

17.

Trimetrexate: predictors of severe or life-threatening toxic effects.

Eisenhauer, E A; Zee, B C; Pater, J L; Walsh, W R.

J Natl Cancer Inst ; 80(16): 1318-22, 1988 Oct 19.

Artigo em Inglês | MEDLINE | ID: mdl-2971818

18.

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Therasse, P; Arbuck, S G; Eisenhauer, E A; Wanders, J; Kaplan, R S; Rubinstein, L; Verweij, J; Van Glabbeke, M; van Oosterom, A T; Christian, M C; Gwyther, S G.

J Natl Cancer Inst ; 92(3): 205-16, 2000 Feb 02.

Artigo em Inglês | MEDLINE | ID: mdl-10655437

19.

Phase I clinical trial design in cancer drug development.

Eisenhauer, E A; O'Dwyer, P J; Christian, M; Humphrey, J S.

J Clin Oncol ; 18(3): 684-92, 2000 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-10653884

20.

Epirubicin in extensive small-cell lung cancer: a phase II study in previously untreated patients: a National Cancer Institute of Canada Clinical Trials Group Study.

Blackstein, M; Eisenhauer, E A; Wierzbicki, R; Yoshida, S.

J Clin Oncol ; 8(3): 385-9, 1990 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-2155308

Portal de Pesquisa da BVS Enfermagem

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar: